The company said it did not receive any observations from USFDA for its Moraiya facility, indicating successful resolution of the warning letter and thereby expects major boost to its US business.
first published: Feb 16, 2017 03:46 pm
A collection of the most-viewed Moneycontrol videos.

This Tenant says Andheri West is better than SOBO | The tenant

Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
You are already a Moneycontrol Pro user.

